Is there hope to treat glioblastoma effectively?

Thomas Mehrling (Mundipharma EDO) speaks to Roshaine Gunawardana, Commissioning Editor of CNS Oncology What led to your interest in specializing in pharmacological science early on in your career? The subject found me! Clearly it was the enthusiasm of my teacher at the time that hooked me up too. I was fascinated that body function could be influenced and healed by pharmacologically active substances and to understand how this works, how the drug works on the body and how the body modifies the drug thrilled me. My teacher, Prof Dr Ernst Mutschler in Frankfurt, took us with such an enthusiasm through...